- Home
- FSI vs BRNS Comparison
FSI vs BRNS Comparison
Compare FSI & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSI
- BRNS
- Stock Information
- Founded
- FSI 1991
- BRNS 2016
- Country
- FSI Canada
- BRNS United Kingdom
- Employees
- FSI N/A
- BRNS N/A
- Industry
- FSI Recreational Games/Products/Toys
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- FSI Consumer Discretionary
- BRNS Health Care
- Exchange
- FSI Nasdaq
- BRNS Nasdaq
- Market Cap
- FSI 46.5M
- BRNS 38.7M
- IPO Year
- FSI 1999
- BRNS 2021
- Fundamental
- Price
- FSI $4.28
- BRNS $0.87
- Analyst Decision
- FSI
- BRNS Strong Buy
- Analyst Count
- FSI 0
- BRNS 2
- Target Price
- FSI N/A
- BRNS $3.00
- AVG Volume (30 Days)
- FSI 24.7K
- BRNS 33.3K
- Earning Date
- FSI 05-23-2025
- BRNS 05-07-2025
- Dividend Yield
- FSI 2.40%
- BRNS N/A
- EPS Growth
- FSI 9.09
- BRNS N/A
- EPS
- FSI 0.24
- BRNS N/A
- Revenue
- FSI $38,234,860.00
- BRNS $14,969,000.00
- Revenue This Year
- FSI $21.91
- BRNS N/A
- Revenue Next Year
- FSI $42.35
- BRNS N/A
- P/E Ratio
- FSI $17.33
- BRNS N/A
- Revenue Growth
- FSI N/A
- BRNS 4381.74
- 52 Week Low
- FSI $1.65
- BRNS $0.64
- 52 Week High
- FSI $7.24
- BRNS $2.45
- Technical
- Relative Strength Index (RSI)
- FSI 54.63
- BRNS 47.94
- Support Level
- FSI $3.55
- BRNS $0.80
- Resistance Level
- FSI $5.09
- BRNS $0.95
- Average True Range (ATR)
- FSI 0.27
- BRNS 0.12
- MACD
- FSI 0.12
- BRNS -0.00
- Stochastic Oscillator
- FSI 47.08
- BRNS 29.70
About FSI Flexible Solutions International Inc. (CDA)
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.